Solventum Corporation

NYSE:SOLV

Medical - Care Facilities

Healthcare
$86.48 -2.61%

-$2.00 today

Market cap
$14.70B
Beta
0.75
P/E (TTM)
9.1
EPS (TTM)
$8.22
52W Low $62.38High $88.20

Volume 0.76M

Average 1.70M

SOLV EBITDA Margin

EBITDA as a percentage of revenue.

Solventum CorporationNYSE: SOLV

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin narrows to 13.8%

EBITDA Margin was 13.8% in Q2 FY2026, down 1.4 pp from a year earlier. On a trailing-twelve-month basis it was 29.7%, up 14.5 pp year over year. Over 3 fiscal years it widened by 2.7 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 11 analysts of 27.0% for the fiscal year ending Dec 2026, down from 30.6% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
13.8%+3.2 pp QoQ
Last fiscal yearDec 2025
30.6%+12.1 pp YoY
LTMJun 2026
29.7%+14.5 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.4 pp-57.4 pp-56.1 pp
1 year+12.1 pp-3.6 pp-15.7 pp
3 years+2.7 pp-3.7 pp-6.4 pp
5 years+0.9 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
30.6%
Year-over-year change
+12.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How SOLV compares with its peers on the latest reported figures

  • SOLV's LTM Jun 2026 EBITDA Margin of 29.7% is the 2nd highest of the 10 companies compared; the peer median is 21.2%.
  • Its year-over-year change of +14.5 pp is the 2nd highest of 10, against a peer median of -0.0 pp.
  • Over three fiscal years its change of +2.7 pp compares with a peer median of +1.0 pp.
SOLV Competitors Peer median
EBITDA Margin for SOLV and competitors
Company Period LTM level YoY 3-year change
UTMDUtah Medical Products, Inc.LTM Mar 202643.6% -2.2 pp-8.8 pp
SOLVSolventum CorporationLTM Jun 202629.7% +14.5 pp+2.7 pp
NVSTEnvista Holdings CorpLTM Oct 202629.0% +16.5 pp-8.2 pp
BDXBecton, Dickinson and CompanyLTM Sep 202623.4% +1.3 pp+1.0 pp
COOThe Cooper Companies, Inc.LTM Jul 202621.5% -5.5 pp-0.8 pp
MMSIMerit Medical Systems, Inc.LTM Sep 202621.2% -0.0 pp+6.2 pp
ICUIICU Medical, Inc.LTM Jun 202611.5% -2.1 pp+5.5 pp
HSICHenry Schein, Inc.LTM Jun 20267.7% +0.2 pp-0.1 pp
BAXBaxter International Inc.LTM Jun 20266.5% -3.0 pp+24.3 pp
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026-3.5% +10.1 pp+15.6 pp
Peer median (excluding SOLV) 21.2%-0.0 pp+1.0 pp

Competitors are the stored peer set for SOLV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue8.17B8.13B8.2B8.25B8.33B
Cost of Revenue3.25B3.44B3.5B3.66B3.87B
Gross Profit4.92B4.7B4.69B4.59B4.45B
Gross Margin60.2%57.7%57.3%55.6%53.5%
Research & Development766M767M758M775M739M
Selling, General & Admin2.28B2.24B2.24B2.78B3.08B
Operating Expenses3.04B3B3B3.56B2.27B
Depreciation & Amortization597M578M561M555M489M
EBITDA2.48B2.27B2.23B1.53B2.55B
EBITDA Margin30.3%27.9%27.2%18.5%30.6%
Operating Income1.88B1.69B1.69B1.04B2.18B
Operating Margin23.0%20.8%20.6%12.6%26.2%
Interest Income00000
Interest Expense000367M347M
Other Income / Expenses3M(1M)(25M)(431M)(468M)
Income Before Tax1.88B1.69B1.67B605M1.71B
Pre-Tax Margin23.0%20.8%20.3%7.3%20.6%
Income Tax Expense422M349M321M127M157M
Net Income1.46B1.34B1.35B479M1.56B
Net Margin17.9%16.5%16.4%5.8%18.7%
EPS (Basic)8.477.797.792.778.94
EPS (Diluted)8.477.797.792.768.88
Weighted Avg Shares172.47M172.47M172.71M173.2M174.1M
Weighted Avg Shares (Diluted)172.47M172.47M172.71M173.7M175.3M

Solventum Corporation

NYSE:SOLV

Intrinsic Alpha fair value

Locked

Current Price

$86.48

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.